Yu Peng

627 total citations
39 papers, 460 citations indexed

About

Yu Peng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yu Peng has authored 39 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Yu Peng's work include Circular RNAs in diseases (9 papers), MicroRNA in disease regulation (8 papers) and Cancer-related molecular mechanisms research (5 papers). Yu Peng is often cited by papers focused on Circular RNAs in diseases (9 papers), MicroRNA in disease regulation (8 papers) and Cancer-related molecular mechanisms research (5 papers). Yu Peng collaborates with scholars based in China, United States and Hong Kong. Yu Peng's co-authors include Wenjing Zhu, Yu‐Zheng Ge, Ruiyang Wu, Yan Zhao, Jianping Wu, Jiageng Zhu, Liuhua Zhou, Wencheng Li, Hui Xin and Luwei Xu and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Yu Peng

34 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Peng China 14 286 191 86 85 42 39 460
Alexandru Tirpe Romania 8 214 0.7× 203 1.1× 67 0.8× 81 1.0× 41 1.0× 13 461
Jinfang Zheng China 12 213 0.7× 150 0.8× 107 1.2× 98 1.2× 31 0.7× 28 398
Deze Zhao China 14 234 0.8× 128 0.7× 152 1.8× 130 1.5× 31 0.7× 22 475
Liping Jiang China 6 184 0.6× 220 1.2× 76 0.9× 80 0.9× 44 1.0× 13 385
Hiroko Seino Japan 14 207 0.7× 135 0.7× 105 1.2× 149 1.8× 82 2.0× 37 511
Yusheng Wang China 13 276 1.0× 200 1.0× 45 0.5× 61 0.7× 43 1.0× 36 527
Hiroto Niizeki Japan 5 229 0.8× 281 1.5× 55 0.6× 117 1.4× 57 1.4× 12 433
Gen Hirano Japan 13 314 1.1× 95 0.5× 96 1.1× 214 2.5× 72 1.7× 22 549

Countries citing papers authored by Yu Peng

Since Specialization
Citations

This map shows the geographic impact of Yu Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Peng more than expected).

Fields of papers citing papers by Yu Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Peng. The network helps show where Yu Peng may publish in the future.

Co-authorship network of co-authors of Yu Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Peng. A scholar is included among the top collaborators of Yu Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Peng. Yu Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yantao, Yu Peng, Zongran Liu, et al.. (2025). Tumor-associated macrophage-derived exosomes modulate the immunotherapeutic sensitivity of SHH-medulloblastoma by targeting m6A-modified FOXD1. Neuro-Oncology. 27(11). 3000–3015. 1 indexed citations
2.
Qiu, Liguo, Yu Peng, Qiang Li, et al.. (2025). Comparative the effect of bisphenol A and bisphenol S on the development and spectral sensitivity of cone photoreceptors in zebrafish larvae (Danio rerio). Ecotoxicology and Environmental Safety. 290. 117737–117737.
3.
4.
5.
Dong, Yating, Yun Wu, Yilu Zhao, et al.. (2025). GluN2A-NMDA receptor inhibition disinhibits the prefrontal cortex, reduces forced swim immobility, and impairs sensorimotor gating. Acta Pharmacologica Sinica. 47(1). 53–68.
6.
Zhou, Jie, Jiuling Wang, Bo Zhou, et al.. (2023). Anti-PD-1 therapy achieves favorable outcomes in HBV-positive non-liver cancer. Oncogenesis. 12(1). 22–22. 4 indexed citations
7.
Sun, Jia, et al.. (2023). Microglia shape AgRP neuron postnatal development via regulating perineuronal net plasticity. Molecular Psychiatry. 29(2). 306–316. 15 indexed citations
8.
Yao, Pu, Qianmei Wang, Qing Dai, et al.. (2023). Cyclic RGD-Functionalized pH/ROS Dual-Responsive Nanoparticle for Targeted Breast Cancer Therapy. Pharmaceutics. 15(7). 1827–1827. 12 indexed citations
9.
Chen, Jianfang, Shuang Wu, Yu Peng, et al.. (2023). Constructing a cancer stem cell related prognostic model for predicting immune landscape and drug sensitivity in colorectal cancer. Frontiers in Pharmacology. 14. 1200017–1200017. 10 indexed citations
10.
Peng, Yu, et al.. (2023). Feasibility of flattening filter free beams for hippocampal avoidance whole-brain radiotherapy: a dosimetric and radiobiological analysis. Frontiers in Oncology. 13. 1290434–1290434. 1 indexed citations
11.
Zhang, Jing, Lingxin Meng, Yu Peng, ­Jun Li­, & Jiadong Yu. (2021). MiR-155 promotes the migration and invasion of esophageal squamous cell carcinoma via downregulating PTEN. Minerva Medica. 112(1). 155–157. 1 indexed citations
12.
Peng, Yu, et al.. (2021). CircTMCO3 Promotes Gastric Cancer Progression by Regulating miR-577/RAB14 Axis. Cancer Management and Research. Volume 13. 6079–6088. 8 indexed citations
13.
Zhu, Wenjing, et al.. (2020). Neuronal calcitonin gene-related peptide promotes prostate tumor growth in the bone microenvironment. Peptides. 135. 170423–170423. 11 indexed citations
14.
15.
Ge, Yu‐Zheng, Luwei Xu, Zheng Xu, et al.. (2015). Expression Profiles and Clinical Significance of MicroRNAs in Papillary Renal Cell Carcinoma. Medicine. 94(16). e767–e767. 22 indexed citations
16.
Ge, Yu‐Zheng, Ruiyang Wu, Hui Xin, et al.. (2015). A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma. Journal of Cancer Research and Clinical Oncology. 141(7). 1291–1299. 39 indexed citations
17.
Peng, Yu, Yu‐Zheng Ge, Yan Zhao, et al.. (2014). Identification and significance of mobilized endothelial progenitor cells in tumor neovascularization of renal cell carcinoma. Tumor Biology. 35(9). 9331–9341. 11 indexed citations
18.
Ge, Yu‐Zheng, Zheng Xu, Luwei Xu, et al.. (2014). Pathway analysis of genome-wide association study on serum prostate-specific antigen levels. Gene. 551(1). 86–91. 13 indexed citations
19.
Tan, Jiaxin, Yu You, Yu Peng, et al.. (2013). Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT. Toxicology Letters. 224(1). 7–15. 33 indexed citations
20.
Lin, Han‐Chieh, et al.. (1996). Effects of long-term administration of octreotide in portal vein-stenosed rats. Hepatology. 23(3). 537–543. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandru Tirpe Breakdown of academic impact, for papers by Jinfang Zheng Breakdown of academic impact, for papers by Deze Zhao Breakdown of academic impact, for papers by Liping Jiang Breakdown of academic impact, for papers by Hiroko Seino Breakdown of academic impact, for papers by Yusheng Wang Breakdown of academic impact, for papers by Hiroto Niizeki Breakdown of academic impact, for papers by Gen Hirano
Rankless by CCL
2026